Similar to This
Previous

BMI, health conditions and medical history decide GLP-1 weight-loss eligibility: GLP-1 weight-loss drug eligibility depends on BMI, specific health conditions ...
qz.com/glp-1-weight-loss-drug-eligibility

US FDA orders new eye risk warnings for Ozempic, Zepbound: The US FDA on Monday informed patients and healthcare providers of a potential increased risk of a ...
philstarlife.com/news-and-views/141677-us-fda-orders-new-eye-risk-warnings-for-ozempic-zepbound

How Ozempic and Zepbound are reshaping 10 industries: Industries affected by GLP-1 drugs like Ozempic and Zepbound range from drugmakers and pen manufacturers to ...
qz.com/industries-affected-glp1-drugs-winners-losers

Paid articlePaywall A bipartisan group of lawmakers urges the FDA to close a peptide loophole: A bipartisan group of lawmakers is urging the FDA to plug a loophole used to import ...
statnews.com/2026/10/20/health-policy-news-bipartisan-group-of-lawmaker-urges-fda-to-close-peptide-loophole/

Paid articlePaywall Lilly’s breast cancer combo wins approval: Today's biotech news includes FDA approval for Eli Lilly's breast cancer combo treatment ...
statnews.com/2026/09/21/biotech-news-lilly-breast-cancer-combo-wins-approval/

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide
cnbc.com/2026/08/12/lilly-lawsuits-obesity-drug-retatrutide.html
Key FactsRetatrutide Stays Experimental Despite Online Buzz
Aug 12, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: marieclaire.com
Summary created with AI assistance · Source: marieclaire.com
- Retatrutide is undergoing Phase 3 trials and has not yet been approved by the FDA.
- In an obesity study, the highest dose produced about 28 percent average weight loss over 80 weeks.
- A laboratory analysis of 10 samples sold online found no substance in two and double doses in three.
- Expected effects include nausea, constipation, reflux, slower digestion, and fatigue; higher doses were also linked to tingling and modestly increased heart rate.
There are no controls. There's no inspections.— Dr. Dubrow says, pointing to an independent laboratory analysis of products sold as retatrutide.

Is the biotech capital of the world moving?: Today's biotech news covers Replimune finally winning FDA approval, the role of tau in Alzheimer's ...
statnews.com/2026/08/07/biotech-news-boston-kendall-square-losing-ground-in-sf/

Paid articlePaywall FDA approves Merck’s oral PCSK9 drug, a first: Today's biotech news covers Kalshi allowing bets on clinical trial outcomes, Eli Lilly buys a psychedelic ...
statnews.com/2026/07/16/biotech-news-fda-approves-merck-oral-pcsk9-drug-in-a-first/

FDA peptides panel includes doctors with ties to industry: The Food and Drug Administration is meeting next month to consider easing restrictions on several ...
apnews.com/article/peptides-fda-rfk-jr-drugs-wellness-dc3eeb67358373d580529c50784af109

Paid articlePaywall FDA appears open to Moderna’s flu vaccine ahead of adcomm: Today's biotech news includes UniQure submitting Huntington's therapy for approval ...
statnews.com/2026/06/17/biotech-news-fda-appears-open-to-moderna-flu-shot/

Gilead and Merck’s latest trial success and flop: Today's biotech news includes AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition ...
statnews.com/2026/06/09/biotech-news-gilead-and-merck-latest-trial-success-and-flop/

Why molecular glue is shaping up to be the next billion-dollar cancer breakthrough
ocregister.com/2026/05/29/molecular-glue-is-shaping-up-to-be-the-next-billion-dollar-cancer-breakthrough-2/

Paid articlePaywall Pharmalittle: We're reading about cheap generic obesity drugs in India, high demand for estrogen patches and more
statnews.com/pharmalot/2026/04/10/pharmalittle-were-reading-about-cheap-generic-obesity-drugs-in-india-high-demand-for-estrogen-patches-and-more/

Biotech investors’ plea to Trump, and a busy M&A week: STAT reporters discuss why an investor-patient coalition sent a letter to President Trump asking for ...
statnews.com/2026/04/02/readout-loud-podcast-biotech-investors-fda-trump-eli-lilly-psychedelics/
Inside Superpower, a peptide startup making people hotter, smarter: 'Do you think you're going to be the one dumb, ugly, tired person?' Inside a San Francisco ...
businessinsider.com/inside-superpower-peptide-startup-people-hotter-smarter-2026-3

Wellness peptide craze: why people are injecting drugs 'not for human consumption'
bbc.co.uk/news/articles/cdr268m5pxro

‘People are turning themselves into lab rats’: the injectable peptides craze sweeping the US
theguardian.com/wellness/2026/feb/05/injectable-peptides-trend

Cigna is putting a cap on weight loss drug costs: The move comes amid an FDA crackdown on cheaper compounded versions of the popular medications
qz.com/cigna-caps-costs-on-popular-weight-loss-drugs-1851781896

WHO recommends two new drugs to combat COVID-19 infection | TheHill: The World Health Organization (WHO) ...
thehill.com/policy/healthcare/589869-who-recommends-two-new-drugs-to-combat-covid-19-infection
Next
